economist glp 1 GLP-1s like Ozempic are among the most important drug breakthroughs ever GLP-1 Drugs - One Thing

Tirzepatide, a dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist, exhibits favourable effects on pancreatic beta-cells and hepatic steatosis in obese type 2 diabetic db/db mice

Citation: Wagih NF, El-Sheikh AA (2021) The Potential Role of GLP-1 Analogues in Cardiovascular Disease Outcomes

Only about 32.3% of patients remain on GLP-1 therapy after one year

GLP-1 out-of-pocket costs range from $199 to over $1,300 per month, depending on the medication and whether its an injection or a pill

Clinical proof-of-concept study with MSDC-0160, a prototype mTOT-modulating insulin sensitizer